Lista de obras - Germano Di Sciascio - Dominio Público Uruguay

A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome

artículo científico publicado en 2012

Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction o

Antiplatelet therapy in patients with diabetes mellitus and acute coronary syndrome.

artículo científico

Apoptosis and Post-infarction Left Ventricular Remodeling

scientific article published on 01 February 2002

Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study.

artículo científico publicado en 2011

Atorvastatin for reduction of myocardial damage during angioplasty trials.

artículo científico publicado en 2010

Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies

artículo científico publicado en 2011

Comparison among patients≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents

artículo científico publicado en 2015

Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin v

artículo científico publicado en 2012

Congenital Absence of Left Atrial Appendage in a Patient with Intracranial Hemorrhage

artículo científico publicado en 2015

Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population

artículo científico publicado en 2003

Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: an unusual case of myocardial rupture

scientific article published on 01 May 2006

Early and long-term results of stenting of diffuse coronary artery disease

artículo científico publicado en 2000

Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction.

artículo científico publicado en 2004

Early prediction of contrast-induced acute kidney injury by a "bedside" assessment of Neutrophil Gelatinase-Associated Lipocalin during elective percutaneous coronary interventions.

artículo científico publicado en 2018

Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention.

artículo científico publicado en 2005

Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

artículo científico publicado en 2009

Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8

artículo científico publicado el 18 de abril de 2013

Giant left ventricular pseudoaneurysm complicating an acute myocardial infarction in patient with previous cardiac surgery: a case report

artículo científico publicado en 2009

Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study

artículo científico publicado en 2015

Hand-held echocardiography in the setting of pre-operative cardiac evaluation of patients undergoing non-cardiac surgery: results from a randomized pilot study.

artículo científico publicado en 2015

High platelet reactivity and periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: A significant association beyond definitions

artículo científico publicado en 2015

High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention

artículo científico publicado en 2010

Impact of Chronic Kidney Disease on Platelet Reactivity and Outcomes of Patients Receiving Clopidogrel and Undergoing Percutaneous Coronary Intervention

artículo científico publicado en 2014

Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention

artículo científico publicado en 2014

Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach

Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting

scientific article published on 01 July 2002

Influence of platelet reactivity on clinical outcome of patients with stable coronary artery disease.

artículo científico

Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease

artículo científico publicado en 2002

Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus.

artículo científico publicado en 2008

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.

artículo científico publicado en 2007

Methylenetetrahydrofolate reductase (MTHFR) C677T genetic polymorphism and late infarct-related coronary artery patency after thrombolysis.

artículo científico publicado en 2008

Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

artículo científico publicado en 2011

Percutaneous Treatment of Recurrent In-Stent Restenosis of Carotid Artery Stenting: A Case Report and State-of-the-Art Review

artículo científico publicado en 2015

Percutaneous closure of a pulmonary arteriovenous malformation in young patient with cryptogenic stroke.

artículo científico publicado en 2013

Percutaneous closure of patent foramen ovale in a patient with situs viscerum inversus

artículo científico publicado en 2013

Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.

artículo científico publicado en 2008

Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction

artículo científico publicado en 2003

Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?

artículo científico publicado en 2012

Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention

artículo científico publicado en 2010

Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platele

artículo científico publicado en 2008

Pressure distension stimulates the expression of endothelial adhesion molecules in the human saphenous vein graft.

artículo científico publicado en 2003

Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) S

artículo científico publicado en 2011

Prognostic role of platelet reactivity in patients with acute coronary syndromes.

artículo científico publicado en 2014

Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization

artículo científico publicado en 2011

Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention

artículo científico publicado en 2002

Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angiopl

artículo científico publicado en 2006

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

artículo científico publicado en 2004

Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study

artículo científico publicado en 2006

Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel.

artículo científico publicado en 2010

Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage dur

artículo científico publicado en 2011

Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery.

artículo científico publicado en 2007

Simvastatin reduces CD40 expression in an experimental model of early arterialization of saphenous vein graft

artículo científico publicado en 2006

Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation.

artículo científico publicado en 2007

Standard- vs high-dose clopidogrel after percutaneous coronary intervention

artículo científico publicado en 2011

Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials

artículo científico publicado en 2015

Statins and percutaneous coronary intervention

scientific article published on 07 January 2005

Statins and their role in pre-percutaneous coronary intervention.

artículo científico publicado en 2010

Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins.

artículo científico publicado en 2011

The ARMYDA trials (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) at Campus Bio-Medico University: rationale, results and future horizons.

artículo científico publicado en 2007

The risks and benefits of drug-eluting stents in the setting of STEMI.

artículo científico publicado en 2008

The use of functional tests and planned coronary angiography after percutaneous coronary revascularization in clinical practice. Results from the AFTER multicenter study

scientific article published on 08 August 2008

Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus

artículo científico publicado en 2013

Transapical closure of paraprosthetic mitral leak in a patient with inferior vena cava interruption and azygos continuation

artículo científico publicado en 2015

Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleed

artículo científico publicado en 2011

Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).

artículo científico publicado en 2013

Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.

artículo científico publicado en 2007

Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis

artículo científico publicado en 2006

Lista de obras de Germano Di Sciascio

A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome

Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction o

Antiplatelet therapy in patients with diabetes mellitus and acute coronary syndrome.

Apoptosis and Post-infarction Left Ventricular Remodeling

Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study.

Atorvastatin for reduction of myocardial damage during angioplasty trials.

Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies

Comparison among patients≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents

Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin v

Congenital Absence of Left Atrial Appendage in a Patient with Intracranial Hemorrhage

Coronary stenting in patients with depressed left ventricular function: acute and long-term results in a selected population

Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: an unusual case of myocardial rupture

Early and long-term results of stenting of diffuse coronary artery disease

Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction.

Early prediction of contrast-induced acute kidney injury by a "bedside" assessment of Neutrophil Gelatinase-Associated Lipocalin during elective percutaneous coronary interventions.

Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention.

Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8

Giant left ventricular pseudoaneurysm complicating an acute myocardial infarction in patient with previous cardiac surgery: a case report

Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study

Hand-held echocardiography in the setting of pre-operative cardiac evaluation of patients undergoing non-cardiac surgery: results from a randomized pilot study.

High platelet reactivity and periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention: A significant association beyond definitions

High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention

Impact of Chronic Kidney Disease on Platelet Reactivity and Outcomes of Patients Receiving Clopidogrel and Undergoing Percutaneous Coronary Intervention

Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach

Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting

Influence of platelet reactivity on clinical outcome of patients with stable coronary artery disease.

Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease

Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus.

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.

Methylenetetrahydrofolate reductase (MTHFR) C677T genetic polymorphism and late infarct-related coronary artery patency after thrombolysis.

Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Percutaneous Treatment of Recurrent In-Stent Restenosis of Carotid Artery Stenting: A Case Report and State-of-the-Art Review

Percutaneous closure of a pulmonary arteriovenous malformation in young patient with cryptogenic stroke.

Percutaneous closure of patent foramen ovale in a patient with situs viscerum inversus

Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.

Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction

Platelet reactivity and percutaneous coronary intervention: another clue in the quest for the Holy Grail of tailored antithrombotic therapy?

Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention

Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platele

Pressure distension stimulates the expression of endothelial adhesion molecules in the human saphenous vein graft.

Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) S

Prognostic role of platelet reactivity in patients with acute coronary syndromes.

Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization

Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention

Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angiopl

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study

Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel.

Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage dur

Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery.

Simvastatin reduces CD40 expression in an experimental model of early arterialization of saphenous vein graft

Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation.

Standard- vs high-dose clopidogrel after percutaneous coronary intervention

Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials

Statins and percutaneous coronary intervention

Statins and their role in pre-percutaneous coronary intervention.

Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins.

The ARMYDA trials (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) at Campus Bio-Medico University: rationale, results and future horizons.

The risks and benefits of drug-eluting stents in the setting of STEMI.

The use of functional tests and planned coronary angiography after percutaneous coronary revascularization in clinical practice. Results from the AFTER multicenter study

Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus

Transapical closure of paraprosthetic mitral leak in a patient with inferior vena cava interruption and azygos continuation

Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleed

Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study).

Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.

Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis